Cited by 162Pituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth FactorsEffects of Radiation Exposure

Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis

Open access
Appelman-Dijkstra, Natasha M., Kokshoorn, Nieke E., Dekkers, Olaf M., Neelis, Karen J., Biermasz, Nienke R., Romijn, Johannes A., Smit, Johannes W. A., Pereira, Alberto M.·2011·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: Cranial radiotherapy is an important cause of hypopituitarism. The prevalence of hypopituitarism varies considerably between studies. OBJECTIVE: We conducted a systematic review and meta-analysis of reported prevalences of hypopituitarism in adults radiated for nonpituitary tumors. DATA SOURCES: We searched PubMed, EMBASE, Web of Science, and the Cochrane Library to identify potentially relevant studies. STUDY SELECTION: Studies were eligible for inclusion with the following criteria: 1) cranial radiotherapy for nonpituitary tumors and/or total body irradiation for hematological malignancies; 2) adult population (>18 yr old); and 3) report on endocrine evaluation. DATA EXTRACTION: Data review was done by two independent reviewers. Besides extraction of baseline and treatment characteristics, also endocrine tests, definitions, and cutoff values used to define pituitary insufficiency were extracted. RESULTS: Eighteen studies with a total of 813 patients were included. These included 608 patients treated for nasopharyngeal cancer (75%) and 205 for intracerebral tumors. The total radiation dose ranged from 14 to 83 and 40 to 97 Gy for nasopharyngeal and intracerebral tumors, respectively. The point prevalence of any degree of hypopituitarism was 0.66 [95% confidence interval (CI), 0.55-0.76]. The prevalence of GH deficiency was 0.45 (95% CI, 0.33-0.57); of LH and FSH, 0.3 (95% CI, 0.23-0.37); of TSH, 0.25 (95% CI, 0.16-0.37); and of ACTH, 0.22 (95% CI, 0.15-0.3), respectively. The prevalence of hyperprolactinemia was 0.34 (95% CI, 0.15-0.6). There were no differences between the effects of radiotherapy for nasopharyngeal vs. for intracerebral tumors. CONCLUSION: Hypopituitarism is prevalent in adult patients after cranial radiotherapy for nonpituitary tumors. Therefore, all patients treated by cranial radiotherapy should have structured periodical assessment of pituitary functions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2011-0306

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [7]7. Shalet SM, Beardwell CG, Morris-Jones P, Bamford FN, Ribeiro GG, Pearson D 1976 Growth hormone deficiency in children with brain tumors. Cancer 37:1144 -1148

Cited by

Sorted by citations

Authors
Appelman-Dijkstra, N. M., Kokshoorn, N. E., Dekkers, O. M., Neelis, K. J., Biermasz, N. R., Romijn, J. A., Smit, J. W. A., & Pereira, A. M.
Affiliations
Leiden University Medical Center (NL)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2011-08
Volume
96
Issue
8
Pages
2330-2340
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2033234433
Cited by
162
References
44
Citations by year
2026: 10 · 2025: 10 · 2024: 15 · 2023: 12 · 2022: 12 · 2021: 9 · 2020: 18 · 2019: 11 · 2018: 10 · 2017: 6 · 2016: 10 · 2015: 8 · 2014: 12 · 2013: 6 · 2012: 7
FWCI
1.29
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
Funders
  • Universiteit Leiden
  • Leids Universitair Medisch Centrum
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
Keywords
hypopituitarism, cranial irradiation, pituitary dysfunction, growth hormone deficiency, gonadotropin deficiency, TSH deficiency, ACTH deficiency, hyperprolactinemia, nasopharyngeal carcinoma, intracerebral tumors, total body irradiation, hematologic malignancies
MeSH terms
Adult, Brain Neoplasms, Humans, Hypopituitarism, Radiotherapy, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review